Suppr超能文献

Incretin response in immune checkpoint inhibitor-induced diabetes: an observational study.

作者信息

Bastin Marie, Busieau Pauline, Kuhn Emmanuelle, Rouault Christine, Taboureau Olivier, Toulgoat Anne, Chelabi Samy, Villemain Aurelie, Wright Jordan J, Spano Jean Philippe, Andreelli Fabrizio

机构信息

Diabetology-Metabolism Department, Sorbonne University, APHP, Institut Hospitalo-Universitaire de Cardiometabolisme et Nutrition (ICAN), Pitié-Salpêtrière-Charles Foix Hospital, F75013 Paris, France.

Diabetology-Metabolism Department, Sorbonne University, APHP, Institut Hospitalo-Universitaire de Cardiometabolisme et Nutrition (ICAN), Pitié-Salpêtrière-Charles Foix Hospital, F75013 Paris, France; Sorbonne Université, INSERM, Nutrition and Obesities: Systemic Approaches (Nutriomics), F-75013, Paris, France.

出版信息

Diabetes Metab. 2021 Sep;47(5):101212. doi: 10.1016/j.diabet.2020.11.004. Epub 2020 Nov 27.

DOI:10.1016/j.diabet.2020.11.004
PMID:33253909
Abstract
摘要

相似文献

1
Incretin response in immune checkpoint inhibitor-induced diabetes: an observational study.
Diabetes Metab. 2021 Sep;47(5):101212. doi: 10.1016/j.diabet.2020.11.004. Epub 2020 Nov 27.
2
Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction.
Int J Clin Pharm. 2013 Apr;35(2):159-72. doi: 10.1007/s11096-012-9729-9. Epub 2012 Dec 22.
3
The journey to understanding incretin systems: Theory, practice and more theory.
J Diabetes Investig. 2019 Sep;10(5):1171-1173. doi: 10.1111/jdi.13123. Epub 2019 Aug 20.
4
Role of incretin-based therapy in hospitalized patients with type 2 diabetes.
J Diabetes Investig. 2020 Mar;11(2):508-509. doi: 10.1111/jdi.13130. Epub 2019 Sep 17.
5
Incretin-based therapies in 2021 - Current status and perspectives for the future.
Metabolism. 2021 Sep;122:154843. doi: 10.1016/j.metabol.2021.154843. Epub 2021 Jul 30.
6
Incretins: the novel therapy of type 2 diabetes.
J Med Assoc Thai. 2008 Jun;91(6):943-54.
7
Novel therapies for the management of type 2 diabetes mellitus: Part 2. Addressing the incretin defect in the clinical setting in 2013.
J Diabetes. 2013 Sep;5(3):241-53. doi: 10.1111/1753-0407.12046. Epub 2013 May 29.
8
Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms.
Oxid Med Cell Longev. 2021 Apr 27;2021:9959320. doi: 10.1155/2021/9959320. eCollection 2021.
9
Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists.
Cardiovasc Diabetol. 2018 Jul 17;17(1):102. doi: 10.1186/s12933-018-0746-4.
10
Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes.
Diabet Med. 2020 May;37(5):868-875. doi: 10.1111/dme.14287. Epub 2020 Mar 11.

引用本文的文献

1
Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction.
J Clin Endocrinol Metab. 2023 May 17;108(6):1514-1525. doi: 10.1210/clinem/dgac689.
2
Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside.
Front Endocrinol (Lausanne). 2021 Nov 5;12:764138. doi: 10.3389/fendo.2021.764138. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验